Related Experiment Video
Updated: Aug 1, 2025

08:10
Author Spotlight: Enhancing Lipid Nanoparticle Formation Through Turbulent Mixing in Confined Geometries
Published on: August 23, 2024
4.0K
Bioinspired Lipid Nanocarriers for RNA Delivery.
Alex Golubovic1, Shannon Tsai1, Bowen Li1,2
1Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario M5S 3M2, Canada.
ACS Bio & Med Chem Au
|April 27, 2023
Summary
Bioinspired design principles enhance RNA delivery vehicles, overcoming challenges like organ localization and poor endosomal escape. This research explores strategies for creating effective lipid nanocarriers for RNA therapeutics.
Area of Science:
- Biotechnology and Nanomedicine
- Drug Delivery Systems
Background:
- RNA therapeutics offer significant potential for treating diseases and enabling personalized medicine.
- Current in vivo RNA delivery faces challenges, including inefficient endosomal escape and off-target organ accumulation with existing lipid nanoparticles.
- Improved delivery vehicles are crucial for realizing the full therapeutic potential of RNA.
Purpose of the Study:
- To review bioinspired design strategies for lipid-based RNA carriers.
- To discuss the implications of these strategies for improving RNA delivery.
- To evaluate strategies based on critical delivery vehicle success factors.
Main Methods:
- Review of literature on bioinspired lipid nanocarriers for RNA delivery.
- Analysis of strategies including incorporation of natural lipids and mimicking biomolecules, viruses, and exosomes.
- Evaluation of strategies against key criteria for effective delivery vehicles.
Main Results:
- Bioinspired modifications can address limitations of current RNA delivery systems.
- Strategies like incorporating natural lipids and mimicking exosomes show promise for enhanced targeting and cellular uptake.
- Specific design principles are being explored to improve endosomal escape and reduce clearance organ localization.
Conclusions:
- Bioinspired lipid nanocarriers represent a promising approach to overcome current RNA delivery hurdles.
- Further research into rational design is needed to optimize these vehicles for clinical translation.
- Successful development of these carriers will significantly advance RNA-based therapeutics.
More Related Videos
Related Concept Videos
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.2K
siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K

